Predicting Benefit from
Interferon Therapy in Melanoma
This section is for people who participated in the following European interferon trials:
- AIM HIGH
- EORTC 18952
- EORTC 18991
Our research team in Leeds has obtained ethical permission to use the data and samples gathered as part of these studies for a new study. For more details please see the study leaflet.
There is also further information for clinicians about the study in the study protocol.
For further information please contact:
Dr. Rosalyn Jewell email@example.com
Section created: 19/12/08
Site and presentations created by NKD Ltd